Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications

Christelle Ferrá(Hospital Universitari Germans Trias i Pujol), A Grañena(Institut Català d'Oncologia), David Gallardo(Instituto Nacional de Cancerología), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Francesc Martí(Duran i Reynals Hospital), CF Lastra(Universitat de Barcelona), Joan Garcı́a(Duran i Reynals Hospital), J J Berlanga(Institut Català d'Oncologia), S de Sanjosé(Institut Català d'Oncologia), Salut Brunet(Institut Català d'Oncologia)
Bone Marrow Transplantation
December 1, 1997
10.1038/sj.bmt.1701023
Cited by 53

Related Papers

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2015|740
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2022|718
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2023|538
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532